Shares of life sciences tools company Agilent Technologies (NYSE:A) jumped 2.8% in the afternoon session after Evercore ISI upgraded the company's stock to 'Outperform' from 'In-Line' and raised its ...
Agilent Technologies President and CEO Padraig McDonnell joins 'Mad Money' host Jim Cramer to talk quarterly results, where it is seeing growth opportunities, the type of research it is supporting and ...
Agilent Technologies reported its fourth-quarter 2025 earnings, surpassing expectations with earnings per share (EPS) of $1.59 compared to a forecast of $1.58. The company’s revenue reached $1.86 ...
Life sciences tools company Agilent Technologies (NYSE:A) will be announcing earnings results this Monday after market hours. Here’s what to expect. Agilent beat analysts’ revenue expectations by 4.3% ...
Agilent Technologies (A) came out with quarterly earnings of $1.37 per share, beating the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.32 per share a year ago. These ...
Agilent stands out as a focused, well-managed leader in life science instruments, with strong financials and resilience amid global trade headwinds. The Ignite transformation program enhances supply ...
Hyderabad: US-based analytical and clinical laboratory technologies player Agilent Technologies Inc has opened its new biopharma experience centre in Hyderabad. The facility will offer advanced ...
Agilent Technologies, a global leader in life sciences, diagnostics, and applied chemical markets opened its new Biopharma Experience Center in Hyderabad, Telangana. The facility marks a significant ...
NYSE-listed global leader in Life Sciences, diagnostics and applied chemical markets Agilent Technologies has established a Biopharma Experience Centre in Hyderabad to support the drug development ...
CHENNAI: Agilent Technologies, a global leader in life sciences, diagnostics, and applied chemical markets, has inaugurated its new Biopharma Capability Center in Hyderabad. The facility represents a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results